Newsroom

Sorted by: Latest
-

AFYREN Obtains ISO 9001 Certification, a Globally Acknowledged Standard of Rigor and Performance, for Its AFYREN NEOXY Plant

CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology based on a circular model, announces that its AFYREN NEOXY industrial site has achieved ISO 9001 certification, a milestone that involves all of the group’s teams. ISO 9001 is the most widely recognized international certification in the field of quality, with over a million companies...
-

AFYREN obtient la certification internationale ISO 9001, synonyme d’exigence et de performance, pour son usine AFYREN NEOXY

CLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa technologie de fermentation unique basée sur un modèle complètement circulaire, annonce l’obtention de la certification ISO 9001 pour son site industriel AFYREN NEOXY, engageant l’ensemble des équipes du groupe. La certification ISO 9001 est la certification la plus reconnue au niveau international dans...
-

Maurel & Prom: Update on the acquisition of additional interests in Blocks 3/05 and 3/05A in Angola

PARIS--(BUSINESS WIRE)--Regulatory News: Etablissements Maurel & Prom S.A. ("M&P", the “Group”) (Paris:MAU) announces an update to the acquisition of interests in Blocks 3/05 and 3/05A offshore Angola, initially announced on 19 June 2025. As part of the transaction process, Sonangol E&P (“Sonangol”), the operator of both blocks, has elected to participate in the acquisition of Etu’s interests. Following this development, M&P, Afentra plc (“Afentra”), and Sonangol will jointly ac...
-

Maurel & Prom : Point sur l’acquisition d’intérêts supplémentaires dans les Blocs 3/05 et 3/05A en Angola

PARIS--(BUSINESS WIRE)--Regulatory News: Établissements Maurel & Prom S.A. (« M&P », le « Groupe ») (Paris:MAU) annonce une mise à jour concernant l’acquisition d’intérêts dans les Blocs 3/05 et 3/05A au large de l’Angola, initialement annoncée le 19 juin 2025. Dans le cadre du processus de transaction, Sonangol E&P (« Sonangol »), opérateur des deux blocs, a décidé de participer à l’acquisition des intérêts d’Etu. M&P, Afentra plc (« Afentra ») et Sonangol acquerront donc conjo...
-

Adenia Hits $180 Million Hard Cap at First Close for Entrepreneurial Fund, Announces First Investment

PORT LOUIS, Mauritius--(BUSINESS WIRE)--Africa-focused private equity firm Adenia Partners closes Entrepreneurial Fund oversubscribed at hard cap of $180 million and invests in Maymana...
-

KnowBe4 Launches AIDA Orchestration as the First Fully Autonomous Agent for Human Risk Management

CAPE TOWN, South Africa--(BUSINESS WIRE)--KnowBe4, the world-renowned platform that comprehensively addresses human and agentic AI risk management, has announced the launch of AIDA Orchestration, the eighth AI-powered agent in KnowBe4’s suite of AI agents for human risk management known as AIDA (Artificial Intelligence Defence Agents). The AIDA Orchestration agent is an autonomous, AI-powered system for human risk management. It independently creates, schedules and manages personalised phishing...
-

Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma announces conference call and webcast for full year 2025 financial results...
-

Innate Pharma organise une conférence téléphonique et un webcast pour présenter ses résultats financiers 2025

MARSEILLE--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd'hui qu'elle organisera une conférence téléphonique le jeudi 26 mars 2026 à 14H00 CET / 9H00 EDT à la suite de la publication de ses résultats financiers pour l’exercice clos le 31 décembre 2025. La conférence sera animée par : Jonathan Dickinson, Directeur Général Sonia Quaratino, Vice-présidente exécutive, Directeur Médical Yannis Morel, Vice-pré...
-

Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the presentation of new clinical data from the global Phase 2 clinical trial (AP-101-02) evaluating the company’s lead program, AP-101, in patients with ALS. AP-101 is an investigational human-derived antibody directed against misfolded superoxide dismutase 1 (SOD1). AP-101 is...
-

NTT DATA Verified the Effectiveness of AI Consumer Agents in Kao’s Product Development Research, Driving Greater Operational Efficiency and Sophistication

TOKYO--(BUSINESS WIRE)--NTT DATA, a global leader in AI, digital business and technology services, today announced the success of its “AI Consumers” proof of concept (PoC) for a makeup brand operated by Kao Corporation, a leading Japanese consumer goods company and a major global cosmetics and personal care manufacturer. The PoC assessed the feasibility of using AI models to simulate the behavioral characteristics of consumers and develop personas to aid product development research. As consume...